{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:59:28Z","timestamp":1791471568363,"version":"4.3.4"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016658","name":"Plan Nacional sobre Drogas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031566","name":"Instituto de Investigaci\u00f3n Sanitaria y Biom\u00e9dica de Alicante","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Increasing psychotropic prescribing has raised concerns about long-term safety and regimen complexity in mental health care. Although psychotherapy is an established treatment, its role in medication optimization and psychotropic medication reduction in real-world practice across patient subgroups remains insufficiently characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate whether initiation of psychotherapy is associated with short-term changes in psychotropic medication exposure and regimen complexity, and to examine differences by sex, age, and diagnostic category. Methods: A retrospective cohort study was conducted using anonymized pharmacy dispensing data from the Mental Health Service of Hospital Marina Baixa (Alicante, Spain) between 2014 and 2024. Patients with at least one active prescription for a benzodiazepine or antidepressant within 90 days before psychotherapy initiation were included. Psychotropic exposure was compared in symmetric 90-day pre- and post-therapy windows using number of active agents, total Defined Daily Doses, and prevalence of benzodiazepine and antidepressant use, with stratified analyses by sex, age group, and diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort comprised 86,502 patients and 20.76 million dispensations. The median number of psychotropic medications decreased from 5 to 2 (p &amp;lt; 0.001), while total dose remained stable (median Defined Daily Dose \u2248 21.7). Benzodiazepine use declined from 87.6% to 67.5% and antidepressant use from 81.8% to 68.8% (both p &amp;lt; 0.001). Men were more likely than women to discontinue benzodiazepines (odds ratio 1.27, 95% confidence interval 1.13\u20131.43), and simplification increased with age (median reduction \u22121 in &amp;lt;18 years to \u22124 in \u226565 years). The largest benzodiazepine reductions occurred in depressive, personality, and episodic mood disorders (\u221223 to \u221227 percentage points).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In routine public mental health care, psychotherapy initiation is associated with substantial simplification of psychotropic treatment regimens without increasing overall medication dose, supporting a potential role in facilitating rational medication simplification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2026.1841866","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T05:39:22Z","timestamp":1782106762000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Psychotherapy initiation is associated with discontinuation of psychotropic medications without dose escalation: a ten-year real-world cohort study (2014-2024)"],"prefix":"10.3389","volume":"17","author":[{"given":"Teresa Dolores","family":"Pomares Carreres","sequence":"first","affiliation":[{"name":"Department of Mental Health, Marina Baixa Hospital, Villajoyosa","place":["Alicante, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Mart\u00ednez Conesa","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Public Health, Faculty of Medicine, University of Murcia","place":["Murcia, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Navarrete","sequence":"additional","affiliation":[{"name":"Instituto de Neurociencias, Universidad Miguel Hern\u00e1ndez-CSIC, San Juan de Alicante","place":["Alicante, Spain"]},{"name":"Red de Investigaci\u00f3n en Atenci\u00f3n Primaria de Adicciones, Instituto de Salud Carlos III, MICINN and FEDER","place":["Madrid, Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria y Biom\u00e9dica de Alicante (ISABIAL)","place":["Alicante, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"B1","article-title":"EPA guidance on improving mental health care through integrative and patient-centered practice","year":"2021"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2016.02.001","article-title":"Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005\u20132012","volume":"26","author":"Bachmann","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1676-z","article-title":"Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications","volume":"70","author":"Abbing-Karahagopian","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1124239","article-title":"Psychotropic drug use in Spain during the COVID-19 pandemic: a population-based registry analysis","volume":"14","author":"Rubio-Valera","year":"2023","journal-title":"Front Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.3390\/ijerph13121177","article-title":"Time trend in psychotropic medication use in Spain: a nationwide population-based study","volume":"13","author":"Carrasco-Garrido","year":"2016","journal-title":"Int J Environ Res Public Health"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2023.03.012","article-title":"Post-pandemic psychotropic prescribing trends in Spain: insights from primary care records","volume":"332","author":"Montero-Mar\u00edn","year":"2023","journal-title":"J Affect Disord"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174730","article-title":"Benzodiazepines, Z-drugs and the risk of hip fracture: a systematic review and meta-analysis","volume":"12","author":"Donnelly","year":"2017","journal-title":"PloS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40268-017-0207-7","article-title":"Benzodiazepines and Z-drugs: an updated review of major adverse outcomes reported in epidemiologic research","volume":"17","author":"Brandt","year":"2017","journal-title":"Drugs R D"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2015.09.003","article-title":"Long-term use of benzodiazepines: definitions, prevalence, and usage patterns \u2013 a systematic review of register-based studies","volume":"30","author":"Kurko","year":"2015","journal-title":"Eur Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12732","article-title":"A systematic review of the emerging definition of \u2018deprescribing\u2019 with network analysis: implications for future research and clinical practice","volume":"80","author":"Reeve","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"B11","article-title":"Deprescribing: a simple method for reducing polypharmacy","volume":"63","author":"Farrell","year":"2017","journal-title":"Can Fam Physician"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing","volume":"175","author":"Scott","year":"2015","journal-title":"JAMA Intern Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s10608-012-9476-1","article-title":"The efficacy of cognitive behavioral therapy: a review of meta-analyses","volume":"36","author":"Hofmann","year":"2012","journal-title":"Cognit Ther Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13335","article-title":"The effects of psychotherapies for depression on response, remission, reliable change, and deterioration: a meta-analysis","volume":"143","author":"Cuijpers","year":"2021","journal-title":"Acta Psychiatr Scand"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.4364","article-title":"Internet-based cognitive behavioural therapy for depression: a systematic review and individual patient data network meta-analysis","volume":"78","author":"Karyotaki","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.189.3.213","article-title":"Strategies for discontinuing long-term benzodiazepine use: meta-analysis","volume":"189","author":"Oude Voshaar","year":"2006","journal-title":"Br J Psychiatry"},{"key":"B17","article-title":"Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines","volume":"44","author":"Bashir","year":"1994","journal-title":"Br J Gen Pract"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.113.134650","article-title":"Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: cluster randomized controlled trial in primary care","volume":"204","author":"Vicens","year":"2014","journal-title":"Br J Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113422","article-title":"Comparative cost-effectiveness of two interventions to discontinue long-term benzodiazepine use: a cluster randomized trial in primary care","volume":"9","author":"Vicens","year":"2014","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd009652","article-title":"Psychosocial interventions for benzodiazepine harmful use, abuse or dependence","author":"Darker","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brat.2003.12.002","article-title":"Long-term outcome after discontinuation of benzodiazepines for insomnia: a survival analysis of relapse","volume":"43","author":"Morin","year":"2005","journal-title":"Behav Res Ther"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2017.12.074","article-title":"Gender differences in antidepressant use and associated factors among older adults in the United States","volume":"261","author":"Kaufmann","year":"2018","journal-title":"Psychiatry Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"6350","DOI":"10.3390\/ijerph18126350","article-title":"Gender differences in the prevalence of mental health, psychological distress and psychotropic medication consumption in Spain: a nationwide population-based study","volume":"18","author":"Maestre-Miquel","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"B25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12877-020-1413-8","article-title":"Reducing inappropriate benzodiazepine use in older adults: the deprescribing implementation study","volume":"20","author":"Lindsay","year":"2020","journal-title":"BMC Geriatr"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12386","article-title":"Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process","volume":"78","author":"Reeve","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"B27","volume-title":"GAIA: Sistema de Informaci\u00f3n de Salud Mental de la Comunidad Valenciana","year":"2024"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.12.016","article-title":"Effectiveness of psychological interventions in preventing recurrence of depressive disorder: meta-analysis and meta-regression","volume":"174","author":"Biesheuvel-Leliefeld","year":"2015","journal-title":"J Affect Disord"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008195","article-title":"Changes in antidepressant use among adults with depression: a population-based study","volume":"5","author":"Kendrick","year":"2015","journal-title":"BMJ Open"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1176\/foc.8.1.foc75","article-title":"Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies","volume":"76","author":"Cuijpers","year":"2008","journal-title":"J Consult Clin Psychol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2020.11.002","article-title":"Systematic implementation of deprescribing in healthcare systems: a narrative review","volume":"17","author":"Reeve","year":"2021","journal-title":"Res Soc Adm Pharm"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2020.09.038","article-title":"Polypharmacy and cognitive decline in older adults: a 10-year longitudinal study","volume":"22","author":"El Rahi","year":"2021","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.13702","article-title":"Updated Beers Criteria for potentially inappropriate medication use in older adults","volume":"67","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1177\/2042098619876545","article-title":"Deprescribing: an essential component of medication optimization and patient safety","volume":"10","author":"Thompson","year":"2019","journal-title":"Ther Adv Drug Saf"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(04)16770-6","article-title":"Borderline personality disorder","volume":"364","author":"Lieb","year":"2004","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1177\/10783903231185353","article-title":"Psychiatric deprescribing: a narrative review","volume":"30","author":"Harding","year":"2024","journal-title":"J Am Psychiatr Nurses Assoc"},{"key":"B37","article-title":"Benzodiazepine use in patients with borderline personality disorder: a clinical review","volume":"9","author":"Sansone","year":"2012","journal-title":"Innov Clin Neurosci"},{"key":"B38","volume-title":"Psychodynamic Psychiatry in Clinical Practice","author":"Gabbard","year":"2021"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1159\/000444196","article-title":"The general neurotic syndrome: a re-evaluation","volume":"46","author":"Tyrer","year":"2016","journal-title":"Psychol Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1037\/1040-3590.12.1.61","article-title":"Acute stress disorder scale: a self-report measure of acute stress disorder","volume":"12","author":"Bryant","year":"2000","journal-title":"Psychol Assess"},{"key":"B41","volume-title":"Medication Safety in Polypharmacy: Technical Report","year":"2019"}],"updated-by":[{"DOI":"10.3389\/fpsyt.2026.1991337","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000}}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1841866\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:36:03Z","timestamp":1791470163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1841866\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":41,"alternative-id":["10.3389\/fpsyt.2026.1841866"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1841866","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"article-number":"1841866"}}